Abstract
Klotho is a well-known life extension factor with the ability to regulate GluN2B-containing N-methyl-D-aspartate receptors (NMDARs). Given that NMDAR dysfunction in the nucleus accumbens (NAc) is a hallmark of major depressive disorder, this study investigated Klotho's role in depression. Using a chronic social defeat stress (CSDS) model, researchers found that Klotho expression significantly decreased in the NAc of mice susceptible to depression. Genetic knockdown of Klotho induced depressive-like behaviors in naive mice, while its overexpression produced antidepressant effects and rescued behaviors in susceptible mice. These effects were mediated by the selective regulation of synaptic GluN2B expression and function. These findings identify Klotho as a novel player in the pathogenesis of depression and a potential therapeutic target.
Introduction
Major Depressive Disorder (MDD) is a complex, debilitating condition and a leading cause of disability worldwide. Despite its prevalence, the molecular mechanisms underlying its development—and why some individuals are resilient while others are susceptible—remain poorly understood. The nucleus accumbens (NAc), a central hub in the brain's reward and motivation circuitry, has emerged as a critical region in the pathophysiology of depression.
Previous research has highlighted the role of N-methyl-D-aspartate receptors (NMDARs), particularly those containing the GluN2B subunit, in the NAc. While GluN2B levels are known to drop during chronic stress, the upstream regulators of this process have been elusive. This study explores the role of Klotho, a protein primarily known for its association with longevity and cognitive health, as a potential regulator of GluN2B function and mood stability.
Methods
To investigate the link between Klotho and depression, researchers utilized a multi-disciplinary approach in mouse models:
- Chronic Social Defeat Stress (CSDS): Mice were exposed to an aggressive CD1 "bully" mouse daily. Following this stressor, they were categorized as "susceptible" (showing social avoidance and anhedonia) or "unsusceptible" (resilient) based on a Social Interaction Test (SIT).
- Viral Manipulation: Adeno-associated virus (AAV) vectors were used to either knock down or overexpress Klotho specifically within the NAc to establish causality.
- Behavioral Assays: Beyond the SIT, the team used the Sucrose Preference Test (SPT) to measure anhedonia, and the Forced Swim Test (FST) and Tail Suspension Test (TST) to assess behavioral despair.
- Molecular and Cellular Analysis: The researchers employed Western blotting to measure protein levels, Golgi staining to visualize dendritic spine density, and electrophysiological recordings to monitor synaptic transmission and plasticity (Long-Term Depression, or LTD).
Results: Klotho as a Molecular Switch
The study first established a correlation between Klotho levels and stress resilience. In mice that developed depressive-like symptoms following CSDS, Klotho expression in the NAc plummeted by approximately 63% compared to control and resilient groups.
To test if this loss of Klotho was a cause rather than just a symptom, the researchers knocked down Klotho in healthy, unstressed mice. This manipulation was sufficient to induce a full suite of depressive-like behaviors, including social withdrawal and reduced interest in rewards. Conversely, overexpressing Klotho in susceptible mice successfully reversed these symptoms, restoring social interaction and sucrose preference to normal levels.
The GluN2B Mechanism
Molecular analysis revealed that Klotho's behavioral effects are tied to its regulation of the GluN2B subunit. Knockdown of Klotho led to a selective decrease in both total and synaptic GluN2B expression in the NAc, mimicking the profile of susceptible mice. Overexpression of Klotho reversed these deficits and normalized the abnormal increases in dendritic spine density typically caused by chronic stress.
Crucially, the antidepressant effects of Klotho were abolished when researchers blocked GluN2B receptors using a specific antagonist (Ro 25-6981). This confirms that Klotho acts as a protective factor by stabilizing GluN2B-containing NMDARs and maintaining healthy synaptic plasticity in the reward center.
Discussion and Future Directions
These findings reveal a novel role for the "longevity factor" Klotho in mental health. While the study clearly demonstrates that increasing GluN2B function via Klotho is antidepressant, it also highlights a paradox in the field: rapid-acting antidepressants like ketamine work by blocking NMDARs. The authors suggest this may be due to the complex, region-specific nature of glutamate signaling or the different downstream growth factors involved.
Future research is needed to determine whether Klotho acts as a transmembrane protein or a secreted hormone in the NAc and to explore its therapeutic potential in human populations. Additionally, as this study focused on male mice, investigating these mechanisms in females will be essential for a comprehensive understanding of Klotho’s role in depression.
Summary updated